Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology

Feng Ming Kong, Kyle C. Cuneo, Li Wang, James A. Bonner, Laurie E. Gaspar, Ritsuko Komaki, Alexander Sun, David E. Morris, Howard M. Sandler, Benjamin Movsas

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: To better define patterns of practice for patients with non-small cell lung cancer (NSCLC) in the United States. Methods and Materials: A survey of 36 questions was designed to collect information regarding practice patterns of radiation oncologists for the management of patients with NSCLC. All American Society for Radiation Oncology members were invited to respond. Results: Four hundred twenty-four responses from radiation oncologists in the United States were received. The response rate for the survey was approximately 20%. Substantial discrepancies were seen in the use of stereotactic body radiation therapy (SBRT) for patients with peripherally and centrally located early-stage tumors and in the recommended SBRT dose. There was a near consensus opinion regarding the use of concurrent chemotherapy and the radiation dose for patients with inoperable stage II and III NSCLC with a good performance status; however, in patients with a poor performance status or in patients with stage IV disease treatment recommendations differed remarkably. Additionally, the use of elective nodal irradiation and the assessment of tumor motion during simulation were highly variable. Thoracic radiation oncologists were more likely to prescribe higher doses, omit elective nodal irradiation, and use advanced technologies (P < .001). Conclusions: Substantial variations were seen in the management of patients with stage I and IV NSCLC in addition to the incorporation of new technology. This information can be used to help design meaningful clinical trials.

Original languageEnglish (US)
JournalPractical Radiation Oncology
Volume4
Issue number2
DOIs
StatePublished - Mar 1 2014

Fingerprint

Radiation Oncology
Non-Small Cell Lung Carcinoma
Radiotherapy
Technology
Neoplasms
Thorax
Clinical Trials
Radiation
Drug Therapy
Radiation Oncologists

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology. / Kong, Feng Ming; Cuneo, Kyle C.; Wang, Li; Bonner, James A.; Gaspar, Laurie E.; Komaki, Ritsuko; Sun, Alexander; Morris, David E.; Sandler, Howard M.; Movsas, Benjamin.

In: Practical Radiation Oncology, Vol. 4, No. 2, 01.03.2014.

Research output: Contribution to journalArticle

Kong, FM, Cuneo, KC, Wang, L, Bonner, JA, Gaspar, LE, Komaki, R, Sun, A, Morris, DE, Sandler, HM & Movsas, B 2014, 'Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology', Practical Radiation Oncology, vol. 4, no. 2. https://doi.org/10.1016/j.prro.2013.05.002
Kong, Feng Ming ; Cuneo, Kyle C. ; Wang, Li ; Bonner, James A. ; Gaspar, Laurie E. ; Komaki, Ritsuko ; Sun, Alexander ; Morris, David E. ; Sandler, Howard M. ; Movsas, Benjamin. / Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology. In: Practical Radiation Oncology. 2014 ; Vol. 4, No. 2.
@article{659b734596e141009e41267028f4632e,
title = "Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology",
abstract = "Purpose: To better define patterns of practice for patients with non-small cell lung cancer (NSCLC) in the United States. Methods and Materials: A survey of 36 questions was designed to collect information regarding practice patterns of radiation oncologists for the management of patients with NSCLC. All American Society for Radiation Oncology members were invited to respond. Results: Four hundred twenty-four responses from radiation oncologists in the United States were received. The response rate for the survey was approximately 20{\%}. Substantial discrepancies were seen in the use of stereotactic body radiation therapy (SBRT) for patients with peripherally and centrally located early-stage tumors and in the recommended SBRT dose. There was a near consensus opinion regarding the use of concurrent chemotherapy and the radiation dose for patients with inoperable stage II and III NSCLC with a good performance status; however, in patients with a poor performance status or in patients with stage IV disease treatment recommendations differed remarkably. Additionally, the use of elective nodal irradiation and the assessment of tumor motion during simulation were highly variable. Thoracic radiation oncologists were more likely to prescribe higher doses, omit elective nodal irradiation, and use advanced technologies (P < .001). Conclusions: Substantial variations were seen in the management of patients with stage I and IV NSCLC in addition to the incorporation of new technology. This information can be used to help design meaningful clinical trials.",
author = "Kong, {Feng Ming} and Cuneo, {Kyle C.} and Li Wang and Bonner, {James A.} and Gaspar, {Laurie E.} and Ritsuko Komaki and Alexander Sun and Morris, {David E.} and Sandler, {Howard M.} and Benjamin Movsas",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.prro.2013.05.002",
language = "English (US)",
volume = "4",
journal = "Practical Radiation Oncology",
issn = "1879-8500",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology

AU - Kong, Feng Ming

AU - Cuneo, Kyle C.

AU - Wang, Li

AU - Bonner, James A.

AU - Gaspar, Laurie E.

AU - Komaki, Ritsuko

AU - Sun, Alexander

AU - Morris, David E.

AU - Sandler, Howard M.

AU - Movsas, Benjamin

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Purpose: To better define patterns of practice for patients with non-small cell lung cancer (NSCLC) in the United States. Methods and Materials: A survey of 36 questions was designed to collect information regarding practice patterns of radiation oncologists for the management of patients with NSCLC. All American Society for Radiation Oncology members were invited to respond. Results: Four hundred twenty-four responses from radiation oncologists in the United States were received. The response rate for the survey was approximately 20%. Substantial discrepancies were seen in the use of stereotactic body radiation therapy (SBRT) for patients with peripherally and centrally located early-stage tumors and in the recommended SBRT dose. There was a near consensus opinion regarding the use of concurrent chemotherapy and the radiation dose for patients with inoperable stage II and III NSCLC with a good performance status; however, in patients with a poor performance status or in patients with stage IV disease treatment recommendations differed remarkably. Additionally, the use of elective nodal irradiation and the assessment of tumor motion during simulation were highly variable. Thoracic radiation oncologists were more likely to prescribe higher doses, omit elective nodal irradiation, and use advanced technologies (P < .001). Conclusions: Substantial variations were seen in the management of patients with stage I and IV NSCLC in addition to the incorporation of new technology. This information can be used to help design meaningful clinical trials.

AB - Purpose: To better define patterns of practice for patients with non-small cell lung cancer (NSCLC) in the United States. Methods and Materials: A survey of 36 questions was designed to collect information regarding practice patterns of radiation oncologists for the management of patients with NSCLC. All American Society for Radiation Oncology members were invited to respond. Results: Four hundred twenty-four responses from radiation oncologists in the United States were received. The response rate for the survey was approximately 20%. Substantial discrepancies were seen in the use of stereotactic body radiation therapy (SBRT) for patients with peripherally and centrally located early-stage tumors and in the recommended SBRT dose. There was a near consensus opinion regarding the use of concurrent chemotherapy and the radiation dose for patients with inoperable stage II and III NSCLC with a good performance status; however, in patients with a poor performance status or in patients with stage IV disease treatment recommendations differed remarkably. Additionally, the use of elective nodal irradiation and the assessment of tumor motion during simulation were highly variable. Thoracic radiation oncologists were more likely to prescribe higher doses, omit elective nodal irradiation, and use advanced technologies (P < .001). Conclusions: Substantial variations were seen in the management of patients with stage I and IV NSCLC in addition to the incorporation of new technology. This information can be used to help design meaningful clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84896697308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896697308&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2013.05.002

DO - 10.1016/j.prro.2013.05.002

M3 - Article

VL - 4

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

SN - 1879-8500

IS - 2

ER -